These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26040666)

  • 1. Impact of heparanase on renal fibrosis.
    Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
    J Transl Med; 2015 Jun; 13():181. PubMed ID: 26040666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.
    Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M
    Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.
    Masola V; Onisto M; Zaza G; Lupo A; Gambaro G
    J Transl Med; 2012 Oct; 10():213. PubMed ID: 23095131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.
    Secchi MF; Masola V; Zaza G; Lupo A; Gambaro G; Onisto M
    Biomol Concepts; 2015 Dec; 6(5-6):415-21. PubMed ID: 26552066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.
    Abassi Z; Hamoud S; Hassan A; Khamaysi I; Nativ O; Heyman SN; Muhammad RS; Ilan N; Singh P; Hammond E; Zaza G; Lupo A; Onisto M; Bellin G; Masola V; Vlodavsky I; Gambaro G
    Oncotarget; 2017 May; 8(21):34191-34204. PubMed ID: 28388547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury.
    Masola V; Zaza G; Gambaro G; Onisto M; Bellin G; Vischini G; Khamaysi I; Hassan A; Hamoud S; Nativ O; Heyman SN; Lupo A; Vlodavsky I; Abassi Z
    PLoS One; 2016; 11(7):e0160074. PubMed ID: 27467172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase.
    Masola V; Zaza G; Granata S; Gambaro G; Onisto M; Lupo A
    J Transl Med; 2013 Nov; 11():292. PubMed ID: 24256696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Brunati AM; Gastaldello A; D'Angelo A; Onisto M; Lupo A
    J Biol Chem; 2012 Jan; 287(2):1478-88. PubMed ID: 22102278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition.
    Masola V; Granata S; Bellin G; Gambaro G; Onisto M; Rugiu C; Lupo A; Zaza G
    Nephrol Dial Transplant; 2017 Jul; 32(7):1145-1154. PubMed ID: 28064160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
    Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury.
    Masola V; Zaza G; Bellin G; Dall'Olmo L; Granata S; Vischini G; Secchi MF; Lupo A; Gambaro G; Onisto M
    FASEB J; 2018 Feb; 32(2):742-756. PubMed ID: 28970256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Heparanse on Organ Fibrosis.
    Masola V; Gambaro G; Onisto M
    Adv Exp Med Biol; 2020; 1221():669-684. PubMed ID: 32274731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase in Kidney Disease.
    van der Vlag J; Buijsers B
    Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
    Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
    Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advancements of heparanase in fibrosis.
    Lv Q; Zeng J; He L
    Int J Mol Epidemiol Genet; 2016; 7(4):137-140. PubMed ID: 28078057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Functions of Heparanase in Human Diseases.
    Jin H; Zhou S
    Mini Rev Med Chem; 2017; 17(6):541-548. PubMed ID: 27804885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential roles of heparanase in cancer therapy: Current trends and future direction.
    Yang Y; Yuan F; Zhou H; Quan J; Liu C; Wang Y; Xiao F; Liu Q; Liu J; Zhang Y; Yu X
    J Cell Physiol; 2023 May; 238(5):896-917. PubMed ID: 36924082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
    Rivara S; Milazzo FM; Giannini G
    Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research progress of endothelial-mesenchymal transition in diabetic kidney disease.
    Chen Y; Zou H; Lu H; Xiang H; Chen S
    J Cell Mol Med; 2022 Jun; 26(12):3313-3322. PubMed ID: 35560773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.